113075-66-4 Usage
Uses
Used in Organic Synthesis:
1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine is utilized as a building block in organic synthesis for the preparation of various biologically active molecules. Its unique structure allows for the creation of diverse chemical entities with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine is employed as a key intermediate in the development of new drugs. Its bromine-substituted naphthalene ring can be further modified to generate compounds with specific pharmacological properties, making it a valuable asset in drug discovery and design.
Potential Therapeutic Applications:
Although further research is required, 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine may have potential therapeutic applications due to its unique chemical structure. Its bromine atom and naphthalene ring could be exploited to develop molecules with specific biological activities, such as targeting certain receptors or enzymes involved in disease pathways.
Safety Precautions:
As a chemical compound, 1-(6-bromo-3,4-dihydronaphthalen-2-yl)pyrrolidine should be handled and used with appropriate safety measures in a controlled laboratory setting. This includes the use of personal protective equipment, proper disposal of waste materials, and adherence to established safety protocols to minimize risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 113075-66-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,0,7 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 113075-66:
(8*1)+(7*1)+(6*3)+(5*0)+(4*7)+(3*5)+(2*6)+(1*6)=94
94 % 10 = 4
So 113075-66-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H16BrN/c15-13-5-3-12-10-14(6-4-11(12)9-13)16-7-1-2-8-16/h3,5,9-10H,1-2,4,6-8H2
113075-66-4Relevant academic research and scientific papers
PHENANTHRENONE COMPOUNDS, COMPOSITIONS AND METHODS
-
Page/Page column 14-15, (2010/04/03)
The present invention is directed to compounds of Formula (I) or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Tricyclic Compound, Compositions, and Methods
-
Page/Page column 12, (2008/12/07)
The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors
-
, (2008/06/13)
The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5α-reductase inhibitors.
Benzo (f) quinolinones as 5-alpha-reductase inhibitors
-
, (2008/06/13)
This invention relates to hexa- and octahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds and methods of their use as steroid 5α reductase inhibitors.
Process for the preparation of benzo (F) quinolinones
-
, (2008/06/13)
This invention relates to a process for the preparation of hexa- and octahydrobenzo[f]quinolin-3-ones.
HEXAHYDROBENZO[F]QUINOLINONES
-
, (2008/06/13)
The invention relates to 1,2,3,4,5,6-hexahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds, and their use as steroid 5alpha-reductase inhibitors.
